Ownership Action Report: Sentiment Report: Corrpro Companies Inc (NYSE:CO)

November 16, 2016 - By Winifred Garcia   ·   0 Comments

Ownership Action Report: Sentiment Report: Corrpro Companies Inc (NYSE:CO)

Sentiment for Corrpro Companies Inc (NYSE:CO)

Corrpro Companies Inc (NYSE:CO) institutional sentiment decreased to 0.57 in 2016 Q2. Its down -0.08, from 0.65 in 2016Q1. The ratio is negative, as 8 hedge funds increased or opened new stock positions, while 14 sold and trimmed equity positions in Corrpro Companies Inc. The hedge funds in our partner’s database now possess: 6.82 million shares, down from 7.04 million shares in 2016Q1. Also, the number of hedge funds holding Corrpro Companies Inc in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 4 Reduced: 10 Increased: 6 New Position: 2.

China Cord Blood Corporation is a provider of cord blood banking services in China. The company has a market cap of $399.78 million. The Firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It has a 26.87 P/E ratio. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee.

About 20,177 shares traded hands. China Cord Blood Corp (NYSE:CO) has declined 20.60% since April 14, 2016 and is downtrending. It has underperformed by 25.29% the S&P500.

According to Zacks Investment Research, “China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with more than one license (i.e., Beijing and Guangdong). Under the current PRC government regulations, only one licensed cord blood bank operator is permitted to operate in each licensed region and only six licenses has been issued as of today. China Cord Blood Corporation collects umbilical cord blood stem cells from newborn babies, and provides laboratory testing, hematopoietic stem cell processing, and stem cell storage services.”

Rock Springs Capital Management Lp holds 0.37% of its portfolio in China Cord Blood Corp for 880,000 shares. Glg Partners Lp owns 923,931 shares or 0.16% of their US portfolio. Moreover, Financial Counselors Inc has 0.03% invested in the company for 86,830 shares. The California-based First Wilshire Securities Management Inc has invested 0.03% in the stock. Seizert Capital Partners Llc, a Michigan-based fund reported 158,194 shares.#img1#

China Cord Blood Corp (NYSE:CO) Ratings Coverage

Ratings analysis reveals 0 of China Cord Blood’s analysts are positive. Out of 2 Wall Street analysts rating China Cord Blood, 0 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. CO was included in 4 notes of analysts from August 21, 2015. The firm has “Neutral” rating given on Friday, August 21 by TH Capital. The stock has “Hold” rating given by Roth Capital on Friday, August 28. The firm has “Sector Perform” rating given on Friday, February 5 by Howard Weil.

CO Company Profile

China Cord Blood Corporation, incorporated on April 10, 2006, is a well-known provider of cord blood banking services in China. The Firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Firm provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The Firm also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. As of March 31, 2016, the Company had three operating cord blood banks in the Beijing municipality, the Guangdong province and the Zhejiang province, the People’s Republic of China.

More notable recent China Cord Blood Corp (NYSE:CO) news were published by: Prnewswire.com which released: “China Cord Blood Corporation to Report Second Quarter and First Half Fiscal …” on November 10, 2016, also Quotes.Wsj.com with their article: “News China Cord Blood Corp.CO” published on January 20, 2010, Prnewswire.com published: “Golden Meditech Enters into Agreements with Nanjing Xinjiekou to Sell China …” on January 07, 2016. More interesting news about China Cord Blood Corp (NYSE:CO) were released by: Prnewswire.com and their article: “China Cord Blood Corporation Receives Notice of Transactions Regarding its 7 …” published on August 26, 2015 as well as Prnewswire.com‘s news article titled: “An Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital” with publication date: March 19, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Winifred Garcia


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>